Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Paving the way toward treatment solutions for CTNNB1 syndrome : a patient organization perspective
Authors:ID Miroševič, Špela (Author)
ID Khandelwal, Shivang (Author)
ID Amerson, Emily (Author)
ID Parks, Effie (Author)
ID Parks, Mariana (Author)
ID Cochran, Lauren (Author)
ID Žakelj, Nina (Author)
ID Lainšček, Duško (Author)
ID Forstnerič, Vida (Author)
ID Sušjan, Petra (Author)
ID Maruna, Matea (Author)
ID Jerala, Roman (Author)
ID Osredkar, Damjan (Author)
Files:URL URL - Source URL, visit https://journals.sagepub.com/doi/10.1177/26330040251318355
 
.pdf PDF - Presentation file, download (1,40 MB)
MD5: 63F9EE6A7A535F705B976C1BD252D046
 
Language:English
Typology:1.02 - Review Article
Organization:Logo KI - National Institute of Chemistry
Publication status:Published
Publication version:Version of Record
Publication date:12.02.2025
Year of publishing:2025
Number of pages:str. 1-13
Numbering:Vol. 6
PID:20.500.12556/DiRROS-21782 New window
UDC:577
ISSN on article:2633-0040
DOI:10.1177/2633004025131835 New window
COBISS.SI-ID:230424323 New window
Copyright:© The Author(s), 2025.
Note:Nasl. z nasl. zaslona; Opis vira z dne 27. 3. 2025;
Publication date in DiRROS:28.03.2025
Views:1033
Downloads:343
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Therapeutic advances in rare disease
Shortened title:Ther. adv. rare dis.
Publisher:SAGE
ISSN:2633-0040
COBISS.SI-ID:114375427 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-4537
Name:POVEZAVA MED GENOTIPOM IN FENOTIPOM PRI SINDROMU CTNNB1 IN NOVI PRISTOPI K ZDRAVLJENJU TEGA SINDROMA

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:01.01.2025
Applies to:License valid from 2025-01-01

Secondary language

Language:Slovenian
Keywords:biokemija, DNK, sindrom, CTNNB1, RNK


Back